Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Announces David J. Elliott to Join Charles River as Corporate Controller

WILMINGTON, Mass., Sep 29, 2005 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that David J. Elliott will join the Company effective October 31, 2005 in the role of Corporate Controller. Mr. Elliott joins Charles River from Cabot Corporation where he served as Corporate Controller. In this position, Mr. Elliott instilled financial controls and positioned the company well for Sarbanes - Oxley.

At Charles River, Mr. Elliott's key responsibilities will include global accounting, financial reporting and compliance with Sarbanes - Oxley. Mr. Elliott will report directly to Thomas Ackerman, Senior Vice President and Chief Financial Officer.

James C. Foster, Chairman, President and Chief Executive Officer of Charles River stated, "I'm pleased to welcome Dave to Charles River. He brings to the Company extensive experience in domestic and international accounting and controls. He has experience in acquisitions and systems implementations and will provide strong leadership as we continue to grow."

About Charles River Laboratories

Charles River Laboratories, based in Wilmington, Massachusetts, is a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Preclinical Services, and Clinical Services. Charles River's customer base includes all of the major pharmaceutical companies and many biotechnology companies, government agencies and leading hospitals and academic institutions. Charles River's 8,000 employees serve clients in more than 50 countries. For more information on Charles River, visit our website at www.criver.com.

SOURCE: Charles River Laboratories

Charles River Laboratories
Elizabeth Ferber, 978-658-6000 ext. 1693
corpcomm@crl.com

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)